Xinhong Wu, PhD
Xinhong Wu, PhD
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of CDK4/6 Inhibitors Combined With Endocrine Therapy in HR+/HER2- Neoadjuvant Therapy for Early Breast Cancer | HR+/HER2- Breast Cancer | Active, not recruiting | Phase 2 | 2025-08-19 | NCT07130643 |